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Review
Manganese is an essential element for all living
organisms and occurs naturally in soil, water,
and plants. The neurotoxicity of manganese
after high occupational exposure by inhalation
has been well documented. Manganism, a
Parkinson-like disorder was first noted in
1837 in ﬁve pyrolusite mill workers and has
since been reported in hundreds of occupa-
tionally exposed workers (Cook et al. 1974;
Greenhouse 1971; Langauer-Lewowicka and
Kujawska 1974; Levy and Nassetta 2003;
Smyth et al. 1973). Manganese is often
regarded as one of the least toxic metals by the
oral route because homeostasis limits the gas-
trointestinal absorption. However, there is
increasing evidence of neurotoxicity by the oral
route especially in infants. They have a more
sensitive nervous system than adults, and their
homeostasis is not fully developed. While
breast milk generally contains low manganese
concentrations, significant amounts can be
found in infant formula. Moreover, because
infant formula is normally sold in powdered
form, the manganese concentration of the
water with which the formula is mixed may
contribute significantly to the infant’s daily
manganese exposure.
Manganese occurs naturally in both surface
and groundwaters, as a result of weathered and
solubilized manganese from soil and bedrock.
Manganese is also deposited into waters from
human activities. According to the Geological
Survey of Sweden (SGU, unpublished data),
manganese concentrations in Swedish ground-
water used for drinking water are on average
150 ± 510 µg/L (median 60 µg/L), with maxi-
mum values as high as 30,000 µg/L. Around
20% of the 12,000 sampled wells had man-
ganese concentrations exceeding the Swedish
recommended guideline value of 300 µg/L.
The U.S. Environmental Protection Agency
(U.S. EPA 2003) reported median manganese
concentrations in groundwater at 5 µg/L, with
the 99th percentile at 2,900 µg/L. In urban
areas, the median groundwater concentration
of manganese was found at 150 µg/L, with the
99th percentile at 5,600 µg/L. In public water
systems supplied by groundwater, approxi-
mately 3% of the 982 sampled sources
exceeded the U.S. health reference level of
300 µg/L (U.S. EPA 2003).
The Current Manganese
Guideline Value for
Drinking-Water Quality
The World Health Organization (WHO) has
recently lowered the guideline value for man-
ganese in drinking water from 500 to
400 µg/L. The previous guideline value of
500 µg/Lwas originally set in 1958 and was at
the time based on the distinct impairment of
water potability by excessive manganese con-
centrations (WHO 2004). This value was
retained in the 1963 and 1971 international
standards as a maximum allowable or permis-
sible manganese concentration. In the first
edition of the WHO guidelines for drinking-
water quality published in 1983, the guideline
value was lowered to 100 µg/L based on the
staining properties of manganese. In the
second edition from 1993, the guideline value
was again raised to 500 µg/L, this time based
on health motives (WHO 2004). The third
and current edition of the WHO guidelines
for drinking-water quality was published in
2006 and presented a health-based guideline
value of 400 µg Mn/L (WHO 2006).
The current health-based guideline value
of 400 µg/L for manganese in water is based
on an estimated no observed adverse effect
level (NOAEL) for manganese in food. To
allow for the possible higher bioavailability of
manganese when ingested with water than
with food (WHO 2004), the NOAEL of
11 mg/day was divided by an uncertainty fac-
tor of three. Using an adult body weight (bw)
of 60 kg, a tolerable daily intake (TDI) of
60 µg Mn/kg bw was derived. On the assump-
tion that 20% of the TDI would be allowed to
come from drinking water, and that an adult
consumes 2 L water/day, the value of 400 µg/L
was set as a health-based guideline value for
drinking water (WHO 2004).
How the NOAEL for manganese was
established. In the background document for
the WHO drinking-water guidelines (WHO
2004), the use of 11 mg as a NOAEL is based
on a review by Greger (1999) and on a report
on dietary reference values for manganese
published by the Institute of Medicine in
2000 (IOM 2001):
A review of typical Western and vegetarian diets
found average adult manganese intakes ranging
from 0.7 to 10.9 mg/day (Greger 1999; Institute
of Medicine [IOM] 2002 [sic]). The upper range
manganese intake value of 11 mg/day from
dietary studies is considered a NOAEL. It is not
believed that this amount of manganese in the diet
represents an overexposure to the element (IOM
2002 [sic]). (WHO 2004)
The IOM in turn, also refers to Greger
(1999):
A NOAEL of 11 mg/day of manganese from food
was identiﬁed based on the data presented by Greger
(1999). Greger (1999) reviewed information indi-
cating that people eating Western-type and vegetar-
ian diets may have intakes as high as 10.9 mg/day of
manganese [. . . .] Because no adverse effects due to
manganese intake have been noted, at least in
people consuming Western diets, 11 mg/day is a
reasonable NOAEL from food. (IOM 2001)
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OBJECTIVE: We reviewed the scientific background for the current health-based World Health
Organization (WHO) guideline value for manganese in drinking water.
DATA SOURCES AND EXTRACTION: The initial starting point was the background document for the
development of the WHO’s guideline value for manganese in drinking water as well as other regu-
lations and recommendations on manganese intake levels. Data referred to in these documents
were traced back to the original research papers. In addition, we searched for scientiﬁc reports on
manganese exposure and health effects. 
DATA SYNTHESIS: The current health-based guideline value for manganese in drinking water is
based partly on debatable assumptions, where information from previous reports has been used
without revisiting original scientific articles. Presently, preparation of common infant formulas
with water containing manganese concentrations equivalent to the WHO guideline value will
result in exceeding the maximum manganese concentration for infant formula. However, there are
uncertainties about how this maximum value was derived. Concurrently, there is increasing evi-
dence of negative neurologic effects in children from excessive manganese exposure.
CONCLUSIONS: The increasing number of studies reporting associations between neurologic symptoms
and manganese exposure in infants and children, in combination with the questionable scientiﬁc
background data used in setting the manganese guideline value for drinking water, certainly warrant a
re-evaluation of the guideline value. Further research is needed to understand the causal relationship
between manganese exposure and children’s health, and to enable an improved risk assessment.
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not focus on manganese intake from different
diets but rather on potential biomarkers of
manganese in human nutrition and toxicol-
ogy. In the introduction section on man-
ganese exposure she stated that “the average
intakes of adults eating Western-type and
vegetarian diets in various surveys ranged
from 0.7–10.9 mg Mn/day,” with reference
to Gibson (1994) and Freeland-Graves
(1994). However, no mention of these values
is made in Gibson (1994), whose article is a
review on trace elements in vegetarian and
omnivorous diets, with a concern for deﬁcien-
cies in vegetarian diets. The Freeland-Graves
(1994) article is also a review published in a
book on risk assessment of essential elements
by the International Life Sciences Institute.
The intake values of 0.7–10.8 mg Mn/day
were observed for Canadian women in a
study carried out by Gibson and Scythes in
1982. These values were also cited in the
Freeland-Graves (1994) review and presented
in a table of daily manganese intakes com-
piled from several studies.
The values used for setting the NOAEL
thus originate from one study, where
100 Canadian women aged 30 ± 6.1 years
were asked to complete dietary protocols of
all consumed foods and beverages (including
drinking water) in their own homes for
3 consecutive weekdays (Gibson and Scythes
1982). The authors present both calculated
and analyzed intake values. The calculated
daily manganese intake ranged from 0.7 to
10.8 mg, where 90% of the women ingested
< 5 mg/day, and almost half the women
(40%) ingested < 2.5 mg/day. The average
daily manganese intake was calculated at
3.1 ± 1.5 mg. The analyzed manganese intake
from duplicate portions provided a slightly
lower average daily manganese intake of
2.4 mg/day. The analyzed maximum intake
was not presented. The slight discrepancy
between the calculated and the analyzed man-
ganese intakes was explained by the authors to
be a result of an overestimation in portion size
(Gibson and Scythes 1982).
The NOAEL of 11 mg/day thus is based
on calculated daily intakes of manganese and
not on actual measurements of manganese
intakes. No mention is made of the subjects’
health statuses or why it seems unfounded to
draw any conclusions on a “no observed
adverse effect level” of daily manganese
intakes at 11 mg. In fact, several studies from
different countries have reported daily man-
ganese intakes after 1982, when the Gibson
and Scythes study was published. Table 1
shows manganese intake data from an array of
countries and ages. Children’s average man-
ganese intake from omnivorous diets was
reported to be about 2 mg/day (mean values
range from 1.3 to 3.6 mg/day), whereas adult
omnivorous diets resulted in a slightly higher
intake of about 2.7 mg/day (mean range
1.5–3.9 mg/day). This value is similar to the
analyzed intake value of 2.4 mg/day reported
by Gibson and Scythes (1982). Both children
and adults with a vegetarian diet have report-
edly higher values of daily manganese intake
than those with an omnivorous diet, which
can be explained by the higher manganese
concentration in plants than in meat and ﬁsh.
The daily intake also seems to differ with
country of residence, likely because of differ-
ing diets. None of the studies found intakes as
high as 11 mg/day.
Manganese Metabolism
in Children
Although the NOAEL for manganese used in
the development of the drinking-water guide-
line value does not seem to have significant
scientiﬁc basis, the current guideline value for
drinking water likely is low enough to protect
the health of adolescents and adults. The rea-
son is that ingested manganese is subject to
delicate homeostatic control, as it is an essen-
tial element. Only a small fraction (1–5%) of
ingested manganese is normally absorbed
from the gastrointestinal tract. The uptake is
regulated so that when dietary manganese lev-
els are high, the gastrointestinal absorption is
reduced. Manganese is also rapidly cleared
from the blood in the liver via excretion in
bile (Aschner et al. 2005; Klaassen 1996).
Infant absorption and excretion, however,
seems to differ from that of adults, although
exact data on human infant manganese
absorption is scarce because of the difﬁculties
in achieving accurate determinations. Dörner
et al. (1989) performed measurements of
infant absorption by using a conventional bal-
ance technique and found that around 20%
of the manganese in formula-fed infants was
absorbed. This value is considerably higher
than those found for adults. The difference
may be due to the lower gastrointestinal pH
and prolonged emptying rate of newborns
compared with those of adults as well as the
immature gastrointestinal tract of newborns
where immature epidermis and increased skin
hydration may facilitate a higher absorption
(Agency for Toxic Substances and Disease
Registry 2000; Milsap and Jusko 1994).
Concurrently, manganese retention is
higher in infants than in adults. According to
Lönnerdal (1994) the bile ﬂow is low in infants,
which may result in a lower excretion of man-
ganese via bile and higher tissue retention.
Moreover, certain tissue sites have a high afﬁn-
ity for manganese, and although these sites are
saturated in adults, they strongly retain man-
ganese in infants. Both hair and blood show
decreasing manganese concentrations with age.
Hatano et al. (1983) reported 3- to 4-fold
higher blood manganese concentrations in
1-month-old infants than in adults. These
results are supported by Rükgauer et al. (1997),
who found a linear decrease in serum man-
ganese concentrations with age when investigat-
ing 137 individuals ranging in age from
1 month to 18 years. Alarcon et al. (1996) also
found a decrease in blood manganese concen-
trations with age when examining 180 infants
ranging in age from 5 days to 12 months,
although the decrease was not as marked as for
the Japanese infants in the Hatano study. In
support, Sakai et al. (2000) reported decreasing
hair manganese concentrations with increasing
age of 418 children and adolescents ranging in
age from 6 months to 20 years.
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Table 1. Daily manganese intake values in children and adults of different nationalities.
Mn intake
Reference Age (years) n, sex Diet Country (mg/day ± SD)
Gibson et al. 1985 1.8–2 36 M + F Omnivore Canada 1.5 ± 0.7
Pennington et al. 1986 2 Omnivore United States 1.5
Schlage and Wortberg 1972 2.8–13 NS Omnivore Germany 1.8 ± 0.4
Gibson 1994 3–6 75 M + F Omnivore  Ghana 2.0 ± 0.5
Aung et al. 2006 3–6 NS Omnivore Japan 1.3 (0.9–1.7)b
Smit Vanderkooy and  4–6 106 M + F Omnivore Canada 2.4 ± 0.9
Gibson 1987 
Leblanc et al. 2005 3–14 NS Omnivore France 1.9 (3.5a)
Cavan et al. 1993  5–8 136 M + F Omnivore Guatemala 3.6 ± 2.0
Gibson 1994 4–7 21 M + F Lactoovoveg Canada 4.3 ± 1.4
Gibson et al. 1989
Gibson 1994 4–6 62 M + F Veg + ﬁsh Malawi 2.7 ± 0.5
Gibson et al. 1991 6–10 67 M + F Veg + ﬁsh Papua New Guinea 3.7 ± 1.9
Roychowdhury et al. 2003 ~10 Veg India 4.9
Ellen et al. 1990 NS Omnivore Holland 3.3
Bro et al. 1990 30–34 100 M Omnivore Denmark 3.9
Leblanc et al. 2005 > 15 NS Omnivore France 2.3 (4.3)a
Aung et al. 2006 28–40 24 F + 1M Omnivore Japan 1.5 (1–4.1)b
Bocio et al. 2005 Estimated  Omnivore Spain 2.4
Biego et al. 1998 Estimated Omnivore France 2.5
Roychowdhury et al. 2003 Estimated  Veg India 4.9
Abbreviations: F, female; Lactoovoveg, lactoovovegetarian; M, male; NS, not speciﬁed; Veg, vegetarian.
a95th percentile. bRange.The decrease in manganese concentration
with age is likely due to both higher absorption
and lower excretion of manganese in early
childhood. Infants are also likely to have a
higher manganese concentration at birth.
Studies on manganese concentrations in cord
blood have reported signiﬁcantly higher con-
centrations than that found in the maternal
blood. Rossipal et al. (2000) and Krachler et al.
(1999) found that the manganese concentra-
tion in umbilical cord serum was 150% higher
than that found in the corresponding maternal
serum. Takser et al. (2003, 2004) reported
geometric mean manganese concentrations in
cord blood collected from 222 newborns in
2003 and from 87 newborns in 2004 at
39 µg/L (range, 15–93 µg/L) and 34 µg/L
(range, 17–90 µg/L), respectively. These values
can be compared with a reference range of
5.0–12.8 µg/L in blood of 100 healthy adult
volunteers in France assessed by Goulle et al.
(2005), who also found a median concentra-
tion of 7.6 µg/L of manganese in blood.
Consequently, infant ingestion of man-
ganese has to be regarded with a different
approach than adult ingestion. Both their
physiology and their behavior influence the
extent of exposure and any potential negative
health effects. It is thus very difﬁcult to accu-
rately extrapolate studies on adults to chil-
dren. Similarly, it is unlikely that the NOAEL
for manganese used in the development of the
current drinking-water guideline is relevant to
child and infant exposure.
Neurotoxicity of manganese. In addition to
a higher absorption and lower excretion of
manganese in infants compared with that in
adults, infants also have a more sensitive ner-
vous system. Although manganese is an essen-
tial element that is needed by the infant to
support normal brain growth and develop-
ment (Dorman et al. 2006), a series of recent
studies report links between excessive man-
ganese exposure and neurologic disorders in
children, mainly in the form of behavioral
effects. Ericson et al. (2006) reported an asso-
ciation between the behavior of twenty-seven
11- and 13-year olds and prenatal manganese
exposure, whereas Takser et al. (2003) found
negative relationships between cord blood
manganese levels and attention, nonverbal
memory, and hand skills at 3 years of age. No
signiﬁcant relationships were found, however,
at 6 years of age. A number of studies have
reported relationships between manganese
exposure from drinking water in particular
and child behavior: A 10-year-old boy who
consumed drinking water with a manganese
concentration of 1,200 µg/L for a period of
5 years showed below average performance on
memory tests but normal results on IQ and
cognitive tests. The boy had elevated whole
blood, urine, and hair manganese concentra-
tions (Woolf et al. 2002). Manganese-related
effects on neurobehavioral performance were
also reported by He et al. (1994) and Zhang
et al. (1995), who examined 92 matched-pair
11- to 13-year olds. The manganese concentra-
tion in the drinking water consumed by the
exposed group of children was 240–350 µg/L
compared to 30–40 µg/L for the control group.
The exposed children had elevated hair (He
et alet al. 1994) and blood (Zhang et al. 1995)
manganese concentrations. They had lower
scores on neurobehavioral tests (He et al. 1994)
and also lower scores in mathematics and lan-
guage (Zhang et al. 1995). Another study of the
relationship between decreased intellectual
functioning and manganese exposure through
drinking water is reported by Wasserman et al.
(2006). They found a dose–response associa-
tion between well-water manganese concentra-
tions and test scores of performance as well as
verbal ability in one hundred forty-two 10-year-
old children. The average manganese concen-
tration in the wells was 800 µg/L and ranged
from 4 to 4,000 µg/L. It should be noted that
the water was sampled 2 years before the neuro-
logic evaluation of the children.
Differences in behavior (hyperactivity,
oppositional behavior) were also reported in
children with different manganese concentra-
tions in their tap water (Bouchard 2007). The
study included 46 children, of whom 28 lived
in houses with elevated manganese levels
(average 600 µg/L) in the tap water. The
water in the houses of the remaining children
had average manganese concentrations of
160 µg/L. The children in the ﬁrst group had
elevated hair manganese concentrations,
which correlated with the water manganese
concentration, suggesting that manganese in
tap water was a signiﬁcant exposure source.
Relationships have thus been found for
different biomarkers, different cognitive tests,
and different sources of exposure. Although
no single study is entirely convincing as to the
level of concern for toxicity in infants and
young children, the number of indicative
studies makes it reasonable to assume that
children are at considerably higher risk for
toxicity than older individuals. It is presently
unclear whether manganese exposure affects
both younger and older children or if negative
symptoms in older children are an effect of
infant exposure. In most studies involving
older children, the children could well have
been exposed since early life, which does not
exclude induction of a neurotoxic effect
already during brain development.
The indicative results on neurobehavioral
effects from excessive manganese exposure in
humans are supported by an experimental
study on infant rhesus monkeys fed infant for-
mula with varying manganese concentrations.
Golub et al. (2005) observed that infants receiv-
ing soy formula (300 µg Mn/L) and soy for-
mula with added manganese (1,000 µg Mn/L)
were engaged in less play and more passive afﬁl-
iation than the control group receiving cow’s
milk (50 µg Mn/L). The formula groups also
had shorter wake cycles and shorter periods of
daytime inactivity. Rodent studies have found
that manganese is accumulated in the infant
brain to a higher extent than in the adult brain
(Dorman et al. 2000; Erikson et al. 2004;
Takeda et al. 1999). However, mixed ﬁndings
have been reported regarding manganese brain
distribution and responses to manganese expo-
sure in rodents (Brenneman et al. 1999; Pappas
et al. 1997; Tran et al. 2002). According to
Dobson et al. (2004), the behavioral changes
observed in both infant humans and rhesus
monkeys from excessive manganese exposure
are not replicable in rodents.
Infant Exposure to Manganese
So far, we have acknowledged that infants
seem to be more susceptible to neurotoxic
effects of excessive manganese exposure, that
their manganese absorption and excretion dif-
fer from that of adults, and that the scientiﬁc
basis of the current guideline value for drink-
ing-water quality is questionable. But to what
degree are infants exposed to manganese
through drinking water?
Children who are breast-fed have a low
exposure to manganese, as breast milk is their
main source of nutrient intake and little man-
ganese is excreted through breast milk.
According to published literature, average
manganese concentrations in human milk
range from 3.1 to 7.5 µg/L, with higher con-
centrations found in the colostrum (Al-Awadi
and Srikumar 2000; Krachler et al. 2000;
Leotsinidis et al. 2005). Parr et al. (1991)
reported manganese concentrations in human
milk collected from mothers in Guatemala,
Hungary, Nigeria, Philippines, Sweden, and
Zaire. The median manganese concentrations
were similar in Sweden, Hungary, and
Guatemala at 3–4 µg/L. In Zaire and Nigeria,
the median manganese concentrations were
slightly higher—11 and 16 µg/L, respectively,
whereas human milk from the Philippines
had the highest median concentration at
40 µg/L. These differences were attributed to
geochemical differences rather than to socio-
economic factors.
Many children, however, are fed with
infant formulas usually purchased in powdered
form and that must be mixed with water before
feeding. Hozyasz and Ruszczynska (2004) ana-
lyzed manganese concentrations in a number of
formulas intended for infants younger than
2 months. They found that standard formulas
contained on average 330 ± 301 µg/L (range,
66–856 µg/L); hypoallergenic formulas based
on partially hydrolyzed cow’s milk proteins
contained 92 ± 52 µg/L (range, 29–173 µg/L);
and special thickened infant formula held
618 ± 531 µg/L (range 89–1,152 µg/L).
Evaluation of water manganese guidelines
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Semper, Mead Johnson Nutritionals, Nutricia,
and Novartis, the manganese concentration of
their infant formulas intended for children
younger than 4 months is between 25 and
600 µg/L (Ljung et al. 2007). The higher con-
centrations are found in some formulas
intended for infants who are allergic or intoler-
ant to breast milk or who suffer from reflux
(hydrolyzed milk whey/protein and soy prod-
ucts), whereas the lowest concentrations are
found in some formulas intended for all infants
(cow’s milk based). However, most formulas,
both standard and allergenic, have manganese
concentrations of about 400 µg/L. Compared
with breast milk, most infant formulas thus
contain approximately 100-fold higher man-
ganese concentrations, not including any addi-
tional manganese from the water with which it
is mixed. The quality of the water used for
preparing infant formula is therefore essential
for the well-being of infants. This was pointed
out in the rolling revision of the WHO drink-
ing-water guideline value where Sievers (2005)
speciﬁcally articulated safety concerns regard-
ing the reconstitution of infant formula with
water containing high manganese concentra-
tions. She also stated that when powdered for-
mulas containing the average manganese
concentration of 325 µg/L are mixed with
drinking water containing manganese equiva-
lent to the WHO guideline value, the maxi-
mum value for manganese in infant formula
set by the European Commission’s Scientiﬁc
Committee on Food (SCF 2003) is exceeded.
Upper limit and adequate daily intake of
manganese for infants. The tolerable upper
limit (UL) of a nutrient is the “highest level of
daily intake that is likely to pose no risk of
adverse health effects in almost all individuals”
(IOM 2001). Neither the SCF, nor the Food
and Nutrition Board IOM were able to set a
tolerable upper limit for manganese intake in
infants younger than 1 year, reportedly because
of the considerable degree of uncertainty on
negative health effects. The authors of the
reports also express a concern regarding the
inability of infants to handle excess amounts of
manganese and state that the intake source
should be from food and formula only to
prevent high intake levels (IOM 2001; SCF
2003). IOM has set a UL for adults above
19 years of age at 11 mg/day by dividing the
estimated NOAEL of 11 mg/day with an
uncertainty factor of 1, based on the lack of
evidence of human toxicity from lower doses.
For younger age groups (from 1 year to
18 years), the UL for adults was extrapolated
and adjusted on the basis of relative body
weight using reference weights (IOM 2001).
The adequate daily intake (AI) of a nutri-
ent is the level at which a sufﬁcient nutrient
intake is provided. The IOM set an AI of
manganese at 3 µg/day for infants younger
than 7 months. The value was calculated by
multiplying the average infant milk consump-
tion (0.78 L/day) with the average manganese
concentration in human milk (3.5 µg/L),
because it is assumed that human milk pro-
vides adequate manganese amounts to exclu-
sively breast fed infants (IOM 2001). The AI
value thereby reﬂects the observed mean man-
ganese intake of infants exclusively fed human
milk from well-nourished mothers.
For infants between 7 and 12 months of
age, the IOM set the AI at 600 µg/day, that
is, markedly higher than that for infants
younger than 7 months. It was based on older
children’s additional manganese intake from
complementary foods (IOM 2001). The
IOM report refers to a study by Gibson and
DeWolfe (1980) in which the average man-
ganese intakes in 6- and 12-month-old
infants were 71 and 80 µg/kg, respectively. By
using reference weights of 7 and 9 kg, the
total average manganese intakes were calcu-
lated at 500 and 720 µg/day, respectively, and
by extrapolating the NOAEL for adults
(11 mg/day), an average daily manganese
intake of 567 µg was attained. By using these
two approaches, an adequate daily intake of
600 µg/day was set (IOM 2000). We have
not been able to ﬁnd the original publication
by Gibson and DeWolfe (1980) that
addresses why it is difﬁcult to have an opinion
on the usefulness of their results in determin-
ing an adequate daily intake value. However,
in the U.S. Food and Drug Administration’s
total diet study by Egan et al. (2002), the
manganese intake in infants 6–11 months of
age was calculated at 410–580 µg/day.
Although the difference between the AI set by
IOM and the upper intake range calculated
by Egan and co-workers may be negligible,
the calculated intake of a 6-month-old infant
is significantly less than the calculated ade-
quate daily intake of 600 µg/L set by IOM.
Maximum value for manganese in infant
formula. In 2003, SCF published a revision
of essential requirements of infant formula (to
be used in the first 4–6 months of life) and
follow-on formula (to be used by infants older
than four months) (SCF 2003). The recom-
mended nutrient intake values were based on
a reference infant of 5 kg with a daily con-
sumption of 0.78 L formula containing
500 kcal (100 kcal/kg bw/day). A maximum
manganese concentration of 100 µg/100 kcal
was recommended for both infant and follow-
on formula. The maximum value was moti-
vated by the following statement:
In spite of the absence of a well identiﬁed UL for
manganese in infants, there is increasing evidence
of the neurotoxicity of high exposure to man-
ganese. Therefore, a maximum manganese content
of 100 µg/100 kcal is proposed, which is below
the estimated LOAEL in adults for manganese in
water (4.2 mg/L). (SCF 2003)
It is not clear how the maximum value was
derived, but the same line of reasoning was
used in the setting of the maximum man-
ganese value in infant formulas by the
Life Sciences Research Office (LSRO), a
U.S.-based nonprofit research organization.
The LSRO also recognized the increasing evi-
dence of manganese toxicity from high expo-
sures and stated that “the proposed maximum
of 100 µg/100 kcal is signiﬁcantly below the
estimated LOAEL in adults for manganese in
water” (Raiten et al. 1998).
LOAEL is the lowest observed adverse
effect level, and there are some questions
regarding the accuracy of its application in set-
ting the maximum value and the interpretation
of the original results from where it is derived.
According to Velazquez and Du (1994) the
LOAEL was based on the ﬁndings of neuro-
logic symptoms similar to those of Parkinson
disease in people older than 50 years, who con-
sumed water with a manganese concentration
of 1,800–2,300 µg/L for older than 10 years
(Kondakis et al. 1989). The LOAEL for the
Kondakis study was identified as 2 mg/L,
which corresponds to 0.06 mg/kg/day
(Velazquez and Du 1994). On the assumption
that a 70-kg person consumes 2-L per day, the
U.S. EPA set the drinking-water LOAEL at
4.2 mg/day (0.06 mg/kg multiplied by 70 kg)
(Greger and Malecki 1997). Note that the
U.S. EPA refers to milligrams per day and the
SCF refers to milligrams per liter. This miscal-
culation results in the use of an LOAEL more
than twice the manganese concentration that
was found in the drinking water resulting in
Ljung and Vahter
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Table 2. Guideline and calculated values for manganese presented for different age groups and in
different units.
Manganese concentration
Parameter Age (months) Assumed weight (kg) µg/100 kcal µg/L µg/day
Max value infant and 0–12 100a 650 500
follow-on formula
Adequate intake 0–6 5 3.8 3b
7–12 7–9 600 600b
LOAEL 0–6 5 385 300
7–12 7–9 420–540 420–540
Adult 70 2,000 4,200c
Intake from formula 0–6 5 650 500
7–12 7–9 700–900 700–900
Data from aSCF (2003), bIOM (2001), and cVelazquez and Du (1994).neurologic symptoms in people older than
50 years. If instead the LOAEL based on body
weight had been used (0.06 mg/kg/day), it
would have resulted in 300 µg/day for a 5-kg
infant, 420 µg/day for a 7-kg infant, and
540 µg/day for a 9-kg infant. On the assump-
tion that a 5-kg infant consumes 0.78 L/day,
the LOAEL for manganese in formula would
then be 385 µg/L, which corresponds to
60 µg/100 kcal. It should also be noted that
the Kondakis study reported ﬁndings on man-
ganese intake in adults older than 50 years, and
not on infants. Table 2 presents the maximum
values for infant formula and the adequate
daily intake values for manganese together with
calculated LOAEL and intake values for differ-
ent age groups and in different units.
In addition to referring to the estimated
LOAEL, the LSRO motivated the maximum
value of 100 µg/100 kcal, corresponding to
650 µg Mn/L, by stating that it is far beyond
the range likely to be encountered in both
milk- and soy based formulas. However, this
is not entirely true because, according to the
producers, infant formulas contain between
25 and 600 µg/L, depending on the brand,
and analyses have found between 30 and
1,150 µg Mn/L (Hozyasz and Ruszczynska
2004; Krachler et al. 2000, 1998). These con-
centrations were found without additional
manganese from drinking water.
Thus, it can be concluded that the maxi-
mum content of manganese in infant formula
is not based on scientiﬁc data on infants but is
instead based on studies of adults, which also
seem to have been misinterpreted. It should
also be noted that the maximum daily man-
ganese intake from formula (500 µg/day) is
about 2 orders of magnitude higher than the
calculated adequate daily intake of 3 µg man-
ganese for infants up to 6 months of age,
which is based on the concentration in breast
milk. The bioavailability of manganese in
drinking water and formula is lower than that
in breast milk, which may justify a higher
concentration. However, it is questionable
whether a 100-fold higher manganese con-
centration in formula is justiﬁable.
Rounding Up
So, what do we know about the scientific
background of the current drinking-water
guideline value so far? We know this:
• The present WHO guideline value for man-
ganese in drinking water is 400 µg/L.
• The guideline value is calculated for adults
older than 19 years, presumably weighing
70-kg and drinking 2 L water per day.
•The guideline value is set based on an
NOAEL of 11 mg Mn/day.
• The NOAEL originates from a study in
which the authors discuss an overestimation
of the calculated daily manganese intake and
where only 10% ingested > 5 mg Mn/day.
• No comments are made on possible toxic
effects in the referenced study or why it is
incorrect to refer to a daily intake of 11 mg
as an NOAEL.
• The average daily manganese intake is simi-
lar regardless of nationality, and although a
vegetarian diet may result in higher daily
intakes, the intake rarely exceeds 5 mg/day.
Time to Re-evaluate the 
Current Guideline Values 
for Drinking Water?
The number of questionable assumptions in
the development of the manganese guidelines,
both for drinking water and for infant for-
mula, in combination with the increasing
number of reports on infant neurotoxicity
from manganese exposure, certainly warrants
a re-evaluation of the current guideline values,
although the need for further research is obvi-
ous. This is an urgent task, as elevated con-
centrations of manganese in drinking water
are quite common in most countries and an
increasing number of people depend on
groundwater for drinking purposes. A re-eval-
uation of the background data used in the cal-
culations of the guideline value would by
itself lower the value. Although a lower value
may not necessarily be required for the major-
ity of the population, sensitive groups such as
infants and possibly also elderly may be at risk
with the present guideline value for drinking
water. Especially children receiving formula,
which generally have greatly elevated man-
ganese concentrations in comparison with
breast milk, may be at risk for neurotoxic
effects if the water used for preparing their
food contains additional manganese.
The importance of good drinking-water
quality for the well-being of children and
infants has been pointed out in the rolling
revision of the WHO drinking-water guide-
line value (Sievers 2005). Regarding man-
ganese, Sievers (2005) speciﬁcally articulated
safety concerns regarding the reconstitution
of infant formula with water containing high
manganese concentrations. Presently, the
maximum value for manganese in infant for-
mula is exceeded when mixing common pow-
dered formulas with water containing
manganese equivalent to the WHO guideline
value. In addition, the maximum value itself
is not based on reliable scientiﬁc grounds.
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